Esperion Therapeutics Inc
ESPR3.690USD
+0.520+16.40%
Close 11/25, 16:00（ET）Quotes delayed by 15 min
758.04MMarket Cap
LossP/E TTM
Esperion Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
332.31M
185.66%
EPS(YoY)
-0.28
86.38%
Analyst Rating
BUY
2025-11-25
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its total revenue reached 332.31M, with a year-on-year change of 185.66%.
What is the Earnings Per Share (EPS) of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.276, with a year-on-year change of 86.38%.
What is the net income of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its net income was -51.74M, with a year-on-year change of 75.27%.
What is the net margin of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its net profit margin was -15.57%, with a year-on-year change of 91.34%.
What is the gross margin of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its gross margin was 79.36%, with a year-on-year change of 26.35%.
What is the debt-to-asset ratio of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 85.01%, with a year-on-year change of -33.12%.
What is the Return on Equity (ROE) of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -18.83%, with a year-on-year change of 79.59%.
What is the operating profit of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its operating profit was 54.40M, with a year-on-year change of 134.97%.
What are the current assets of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its current assets were 338.00M, with a year-on-year change of 68.10%.
What are the total assets of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its total assets of Esperion Therapeutics Inc were 343.82M, with a year-on-year change of 67.07%.
What are the total liabilities of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its total liabilities of Esperion Therapeutics Inc were 732.54M, with a year-on-year change of 10.86%.
What is the total equity of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its total equity of Esperion Therapeutics Inc was -388.72M, with a year-on-year change of 14.57%.
What is the net operating income of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its net operating income of Esperion Therapeutics Inc was -51.74M, with a year-on-year change of 75.27%.
What is the net investment of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its net investment of Esperion Therapeutics Inc was -317.00K, with a year-on-year change of -100.75%.
What is the net financing of Esperion Therapeutics Inc?
According to Esperion Therapeutics Inc's FY2024 earnings report, its net financing of Esperion Therapeutics Inc was 86.48M, with a year-on-year change of 71.39%.
